Opus Genetics (IRD) Current Taxes (2022 - 2023)
Opus Genetics (IRD) posted quarterly Current Taxes of $11000.0 for Q3 2023, down 96.51% quarter-over-quarter from $315000.0 in Q1 2023.
Powered by 
Analysis
Opus Genetics (IRD) Current Taxes (2022 - 2023) Analysis & Trends
Opus Genetics (IRD) has reported Current Taxes for 2 consecutive years, with $11000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Current Taxes changed N/A year-over-year to $11000.0; the TTM figure through Sep 2023 stood at $11000.0 (changed N/A YoY), while the FY2022 annual figure was $315000.0, changed N/A from the prior year.
- Current Taxes declined to $11000.0 in Q3 2023 per IRD's latest filing, from $315000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $315000.0 in Q4 2022 and bottomed at $11000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Opus Genetics | 446.86 Mn | 358.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 11,000.00 |
| Mar 31, 2023 | 315,000.00 |
| Dec 31, 2022 | 315,000.00 |